Globus Medical (GMED)
(Real Time Quote from BATS)
$57.85 USD
+0.01 (0.02%)
Updated Sep 17, 2025 11:04 AM ET
3-Hold of 5 3
B Value C Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
GMED 57.85 +0.01(0.02%)
Will GMED be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GMED
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
SP Platform's 88% Procedure Growth: The Next Frontier for ISRG?
ISRG's Ion Platform Procedure Grows 52%: Can This Trend Continue?
Other News for GMED
Is GMED positioned for a breakout? 50 Day Moving Average Support shows up after dropping 0.69%
GMED forms Stochastic Buy Signal on September 15
Insider Sell: Ann Rhoads Sells 10,000 Shares of Globus Medical Inc (GMED)
GMED falls 1.48% on September 12, leaving the technical picture intact
Bullish Engulfing appears for GMED after 2.02% move